ClinicalTrials.gg
CompletedNCT06022484Updated Feb 6, 2024

Magnetic Resonance Imaging and Acute Low Back Pain

An observational study in Acute Low Back Pain, sponsored by International Institute of Behavioral Medicines. Completed at 1 site in Italy. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2024-02-06.

Sponsored by International Institute of Behavioral Medicines · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
100
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 56 studies in Low Back Pain with a site in Italy — 12 open to participants now, 13 under way, 1 of them phase 3. Low Back Pain · Italy.

Enrollment
9th of 15
100 · median 104
Started
2023
with 6 others
Observational
16 of 56
5 open now
Registered
44th of 56
by date
Lead sponsor
3 of 56
International Institute of Behavioral Medicines

Among the 56 studies in Low Back Pain with a site in Italy, this one is the 9th largest by enrollment of the 15 observational ones that give a count, is one of 7 that started in 2023, is one of 16 observational ones, and was the 44th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

12 of the 56 studies in Low Back Pain with a site in Italy are open now. Recruiting first, the newest first:

7 more — sign in →

All 12 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 56 studies in Low Back Pain with a site in Italy, or all of them as a file.
02

Study summary

This is a behavioral observational study aimed at understanding the limit of tolerance (in days) of ideally performing a Magnetic Resonance Imaging (MRI) by people with acute low back pain. It consists of a short self-administered questionnaire. Relationships between low back pain intensity, maladaptive thoughts and awaited days before ideally requesting a MRI will be evaluated.

Read the detailed description

This is a behavioral observational study aimed at understanding the limit of tolerance (in days) of ideally performing a Magnetic Resonance Imaging (MRI) by people with acute low back pain (LBP) and by general practitioners (GP).

Literature pointed out that LBP is a common occurrence in people, with high rates of self-resolution in the absence of red flags (i.e. possible indicators of serious spinal pathology).

In Italy there is an over-prescription of MRI despite international guidelines go the opposite way.

The study consists of a short self-administered questionnaire which will be given to people and GP to complete. In more details, the survey is made of 3 questions collecting information on the limit of tolerance (in days) before requesting (people) and prescribing (GP) a MRI for the lumbar tract of the spinal column.

Further, participants will have to complete a self-administered pain intensity numerical rating scale, along with catastrophizing and anxiety self-administered questionnaires.

Descriptive statistics will be presented by taking into account the socio-demographic characteristics of the sample being investigated. Statistical correlations between participants' answers and the scores from the questionnaires will be also evaluated.

This study investigates the relationships among acute low back pain, the intention of persons/GP to request/prescribe a MRI despite the absence of red flags, mood disorders and maladaptive thoughts.

03

Conditions studied

  • Acute Low Back Pain

Keywords

  • Low back pain
  • Magnetic Resonance Imaging
  • Catastrophizing
  • Anxiety
  • Red flags
04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adult people with acute low back pain (i.e., a pain lasting no more than 6 weeks).

General practitioners who are involved in the managment of people with acute low back pain.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Having acute low back pain (i.e., a pain lasting no more than 6 weeks)
  • Adult age
  • Ability to understand the Italian language

Exclusion criteria

Exclusion Criteria:

  • Mental deficits
  • Refuse to adhere to the study.
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • People with acute low back pain

    No intervention.

    Other: The present study does not contain any intervention

  • General practitioners who treat people with acute low back pain

    No intervention.

    Other: The present study does not contain any intervention

Interventions

  • OtherThe present study does not contain any intervention

    The present study does not contain any intervention

06

What researchers measure

Primary outcomes

  1. Two questions on limit of tolerance

    Design of questions which investigates the limit of tolerance of requesting and prescribing a MRI; score is expressed as "number of days" (neither min nor max values are stated a priori).

    Time frame: Up to the first day

Secondary outcomes

  1. NRS

    pain intensity Numerical Rating Scale; score 0-10 with higher estimates indicating higher levels of pain intensity

    Time frame: Up to the first day

  2. PCS

    Pain Catastrophizing Scale; score 0-52 with higher estimates indicating higher levels of catastrophizing.

    Time frame: Up to the first day

  3. ZUNG

    Zung Self-Rating Anxiety Scale; score 20-80 with higher estimates indicating higher levels of anxiety

    Time frame: Up to the first day

07

Study locations

1 site
  • Barbara Rocca
    Calosso, Italy
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Sep 2023 to primary completion in Dec 2023, 3 months.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 21, 2023
First posted
Sep 5, 2023
StartActual
Sep 15, 2023
Primary completionActual
Dec 31, 2023
CompletionActual
Dec 31, 2023
Last update
Feb 6, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 6, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06022484
Lead sponsor
International Institute of Behavioral Medicines
Responsible party
Sponsor
First posted
Sep 5, 2023
Start date
Sep 15, 2023
Primary completion
Dec 31, 2023
Completion
Dec 31, 2023
Last update
Feb 6, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion